Sana Biotechnology, Inc. (SANA) Institutional Ownership

Ownership Summary

Sana Biotechnology, Inc. (NASDAQ:SANA) showed up in the 13F filings of 197 institutional investors as of December 2025.

• These investors collectively held 61.0% of Sana Biotechnology's outstanding shares in December 2025, down from 64.0% in September 2025.
• They decreased total shares held in Sana Biotechnology by -3.66% from the prior quarter, while the number of investors in SANA increased 22.36% year over year.
• Among the 197 funds, 110 bought more Sana Biotechnology shares, 50 sold down, and 37 held their ground.
• The aggregate institutional position in Sana Biotechnology amounted to 158.95Mn shares as of December 2025, down by 6.04Mn shares quarter on quarter, and down 1.33Mn shares year over year.
• As of December 31, 2025, the biggest holder of Sana Biotechnology is FMR LLC at 37.43Mn shares, representing 14.37% of shares outstanding.
• The most significant purchases of SANA for the quarter ending December 2025 came from BlackRock, Inc. (3.0Mn), BALYASNY ASSET MANAGEMENT L.P. (1.68Mn), State Street Corp (1.37Mn), VANGUARD GROUP INC (1.33Mn), Integral Health Asset Management, LLC (1.0Mn).
• Leading sellers of Sana Biotechnology shares for the quarter ending December 2025 were CITADEL ADVISORS LLC (6.54Mn), BAILLIE GIFFORD & CO (4.83Mn), Jpmorgan Chase & Co (3.46Mn), BAKER BROS. ADVISORS LP (1.72Mn), MILLENNIUM MANAGEMENT LLC (996.76K).
• Per Business Quant data, the top 10 holders of Sana Biotechnology for the quarter ending December 2025 are FMR LLC (37.43Mn), Flagship Pioneering, LLC (25.0Mn), BlackRock, Inc. (14.22Mn), VANGUARD GROUP INC (10.46Mn), CANADA PENSION PLAN INVESTMENT BOARD (10.24Mn), State Street Corp (8.05Mn), BAILLIE GIFFORD & CO (6.61Mn), GEODE CAPITAL MANAGEMENT, LLC (4.12Mn), Marex Group plc (3.73Mn), Integral Health Asset Management, LLC (3.0Mn).